Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma.
Phase of Trial: Phase I
Latest Information Update: 20 Dec 2016
At a glance
- Drugs Cancer vaccine (Primary) ; Imiquimod (Primary) ; Montanide ISA-51
- Indications Cancer metastases; Malignant melanoma
- Focus Adverse reactions
- 15 Dec 2016 Status changed from suspended to completed.
- 20 Sep 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 29 Jun 2012 Planned End Date changed from 1 Jun 2012 to 1 Jun 2015 as reported by ClinicalTrials.gov.